Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, United States of America.
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, United States of America.
PLoS One. 2019 Sep 3;14(9):e0220908. doi: 10.1371/journal.pone.0220908. eCollection 2019.
Acute respiratory tract infections are a major cause of respiratory morbidity and mortality in pediatric patients worldwide. However, accurate viral and immunologic markers to predict clinical outcomes of this patient population are still lacking. Droplet digital PCR assays for influenza and respiratory syncytial virus (RSV) were designed and performed in 64 respiratory samples from 23 patients with influenza virus infection and 73 samples from 19 patients with RSV infection. Samples of patients with hematologic malignancies, solid tumors, or sickle cell disease were included. Clinical information from institutional medical records was reviewed to assess disease severity. Samples from patients with fever or respiratory symptoms had a significantly higher viral loads than those from asymptomatic patients. Samples from patients with influenza virus and RSV infection collected at presentation had significantly higher viral loads than those collected from patients after completing a course of oseltamivir or ribavirin, respectively. RSV loads correlated positively with clinical symptoms in patients ≤5 years of age, whereas influenza viral loads were associated with clinical symptoms, irrespective of age. Patients receiving antivirals for influenza and RSV had a significant reduction in viral loads after completing therapy. Digital PCR offers an effective method to monitor the efficacy of antiviral treatment for respiratory tract infections in immunocompromised hosts.
急性呼吸道感染是全球儿科患者呼吸道发病率和死亡率的主要原因。然而,仍然缺乏准确的病毒和免疫标志物来预测这类患者人群的临床结局。针对流感病毒和呼吸道合胞病毒(RSV)设计并进行了 64 份呼吸道样本的数字 PCR 检测,这些样本来自 23 例流感病毒感染患者和 19 例 RSV 感染患者。样本包括血液恶性肿瘤、实体瘤或镰状细胞病患者。回顾机构病历中的临床信息,以评估疾病严重程度。有发热或呼吸道症状的患者样本的病毒载量明显高于无症状患者。在开始接受奥司他韦或利巴韦林治疗之前采集的流感病毒和 RSV 感染患者样本的病毒载量明显高于治疗完成后的患者。≤5 岁的患者中,RSV 载量与临床症状呈正相关,而流感病毒载量与临床症状相关,与年龄无关。接受流感和 RSV 抗病毒治疗的患者在完成治疗后病毒载量显著降低。数字 PCR 为监测免疫功能低下宿主呼吸道感染的抗病毒治疗效果提供了一种有效方法。